CALLEGARI, DONATELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.031
AS - Asia 776
EU - Europa 712
SA - Sud America 92
AF - Africa 59
Totale 2.670
Nazione #
US - Stati Uniti d'America 1.007
SG - Singapore 260
CN - Cina 220
IT - Italia 220
VN - Vietnam 129
IE - Irlanda 103
FR - Francia 86
SE - Svezia 78
BR - Brasile 74
FI - Finlandia 57
HK - Hong Kong 51
DE - Germania 46
TR - Turchia 34
ZA - Sudafrica 34
GB - Regno Unito 25
NL - Olanda 21
BE - Belgio 17
CI - Costa d'Avorio 16
IN - India 15
RU - Federazione Russa 13
TH - Thailandia 12
CA - Canada 11
ID - Indonesia 10
MX - Messico 10
BD - Bangladesh 8
CZ - Repubblica Ceca 8
PH - Filippine 8
ES - Italia 7
JP - Giappone 7
PL - Polonia 7
AR - Argentina 6
VE - Venezuela 6
HR - Croazia 4
MA - Marocco 4
PK - Pakistan 4
UA - Ucraina 4
AT - Austria 3
IQ - Iraq 3
KR - Corea 3
LT - Lituania 3
RO - Romania 3
SI - Slovenia 3
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
BB - Barbados 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
TJ - Tagikistan 1
Totale 2.670
Città #
Singapore 133
Chandler 132
Ann Arbor 122
Ashburn 116
Dublin 103
San Jose 75
Parma 69
Dallas 67
Santa Clara 56
Hong Kong 50
New York 46
Ho Chi Minh City 44
Beijing 43
Dearborn 41
Johannesburg 33
Izmir 26
Shanghai 26
Hanoi 25
Boardman 23
Los Angeles 20
Nanjing 19
Abidjan 16
Princeton 16
Brussels 14
Dong Ket 14
Wilmington 14
Bremen 13
Lauterbourg 13
Hefei 12
Shenyang 12
Munich 11
Modena 9
São Paulo 9
Chennai 7
Jakarta 7
Jinan 7
Bangkok 6
Columbus 6
Follonica 6
Helsinki 6
San Mateo 6
Soliera 6
Tokyo 6
Warsaw 6
Woodbridge 6
Ankara 5
Brescia 5
Chicago 5
Da Nang 5
Haiphong 5
Mexico City 5
Milan 5
Moscow 5
Orem 5
Poplar 5
Prata Di Pordenone 5
Rome 5
The Dalles 5
Brno 4
Brooklyn 4
Denver 4
Frankfurt am Main 4
Grafing 4
Jiaxing 4
Kunming 4
Lubbock 4
Manaus 4
New Delhi 4
Sant'ilario D'enza 4
Seattle 4
Trieste 4
Zagreb 4
Atlanta 3
Borås 3
Buffalo 3
Campinas 3
Caorso 3
Council Bluffs 3
Dhaka 3
Düsseldorf 3
Fremont 3
Guangzhou 3
Hebei 3
Houston 3
Joinville 3
Montreal 3
Nanchang 3
Norwalk 3
Nuremberg 3
Rio de Janeiro 3
San Francisco 3
Seoul 3
Stockholm 3
Tianjin 3
Toronto 3
Trento 3
Turku 3
Vienna 3
Vigevano 3
Addis Ababa 2
Totale 1.701
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 350
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 214
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 202
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 201
N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations 174
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 161
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 160
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 148
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 146
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 145
L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib 143
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells 140
Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations 138
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 138
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8. 133
Eph-ephrin antagonism in tumor angiogenesis and growth: UniPR1331 preclinical evidence. 132
Totale 2.725
Categoria #
all - tutte 8.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 9 6 26
2021/2022151 4 6 9 25 3 10 27 9 2 12 10 34
2022/2023410 35 51 26 44 38 43 3 26 119 4 19 2
2023/2024149 7 5 3 2 11 47 20 8 5 6 17 18
2024/2025411 19 21 38 10 50 39 20 16 58 36 45 59
2025/2026958 91 98 107 118 142 62 83 32 126 99 0 0
Totale 2.725